Shielding of a lipooligosaccharide IgM epitope allows evasion of Neutrophil-Mediated killing of an invasive strain of nontypeable Haemophilus influenzae

mBio

Volumn 5, Issue 4, 2014, Pages 1-10

  Langereis, Jeroen D ^a   Weiser, Jeffrey N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; EPITOPE; GALACTOSE; GLUCOSE; HEPTOSE; IMMUNOGLOBULIN M; LIPOOLIGOSACCHARIDE; SERINE PROTEINASE; OLIGOSACCHARIDE;

ANTIGEN BINDING; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CARBOHYDRATE ANALYSIS; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT FIXATION; CONTROLLED STUDY; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNE EVASION; NEUTROPHIL; NONHUMAN; NONTYPEABLE HAEMOPHILUS INFLUENZAE; OPSONIZATION; PHAGOCYTOSIS; SEQUENCE ANALYSIS; TRANSPOSON; CELL CULTURE; HAEMOPHILUS INFLUENZAE; IMMUNOLOGY; METABOLISM;

HAEMOPHILUS INFLUENZAE;

CELLS, CULTURED; EPITOPES; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNOGLOBULIN M; NEUTROPHILS; OLIGOSACCHARIDES;

EID: 84908272897     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01478-14     Document Type: Article

References (58)

1. Heath PT. 1998. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatr. Infect. Dis. J. 17:S117-S122. http://dx.doi.org/10.1097/00006454-199809001-00005.
2. Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME, European Union Invasive Bacterial Infection Surveillance.2010. Invasive Haemophilus influenzae disease, Europe, 1996-2006. Emerg. Infect. Dis. 16:455-463. http://dx.doi.org/10.3201/eid1603.090290.
3. Stol K, Verhaegh SJ, Graamans K, Engel JA, Sturm PD, Melchers WJ, Meis JF, Warris A, Hays JP, Hermans PW. 2013. Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion. Int. J. Pediatr. Otorhinolaryngol. 77: 488-493. http://dx.doi.org/10.1016/j.ijporl.2012.12.016.
4. Brook I. 2011. Microbiology of sinusitis. Proc. Am. Thorac. Soc. 8:90-100. http://dx.doi.org/10.1513/pats.201006-038RN.
5. Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, Murphy TF. 2007. Airwaybacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 176:356-361. http://dx.doi.org/10.1164/rccm.200703-417OC.
6. Hallström T, Resman F, Ristovski M, Riesbeck K. 2010. Binding of complement regulators to invasive nontypeable Haemophilus influenzae isolates is not increased compared to nasopharyngeal isolates, but serum resistance is linked to disease severity. J. Clin. Microbiol. 48:921-927. http://dx.doi.org/10.1128/JCM.01654-09.
7. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. 2000. Association between airwaybacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am. J. Med. 109:288-295. http://dx.doi.org/10.1016/S0002-9343(00)00507-6.
8. Kolaczkowska E, Kubes P. 2013. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13:159-175. http://dx.doi.org/10.1038/nri3399.
9. Lysenko ES, Ratner AJ, Nelson AL, Weiser JN. 2005. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog. 1:e1. http://dx.doi.org/10.1371/journal.ppat.0010001.
10. Juneau RA, Pang B, Weimer KE, Armbruster CE, Swords WE. 2011. Nontypeable Haemophilus influenzae initiates formation of neutrophil extracellular traps. Infect. Immun. 79:431-438. http://dx.doi.org/10.1128/IAI.00660-10.
11. Hong W, Juneau RA, Pang B, Swords WE. 2009. Survival ofbacterial biofilms within neutrophil extracellular traps promotes nontypeable Haemophilus influenzae persistence in the chinchilla model for otitis media. J. Innate Immun. 1:215-224. http://dx.doi.org/10.1159/000205937.
12. Langereis JD. 2013. Neutrophil integrin affinity regulation in adhesion, migration, andbacterial clearance. Cell Adh. Migr. 7:476-481. http://dx.doi.org/10.4161/cam.27293.
13. Hallström T, Jarva H, Riesbeck K, Blom AM. 2007. Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance. J. Immunol. 178:6359-6366. http://dx.doi.org/10.4049/jimmunol.178.10.6359.
14. Hallström T, Zipfel PF, Blom AM, Lauer N, Forsgren A, Riesbeck K. 2008. Haemophilus influenzae interacts with the human complement inhibitor factor H. J. Immunol. 181:537-545. http://dx.doi.org/10.4049/jimmunol.181.1.537.
15. Langereis JD, Stol K, Schweda EK, Twelkmeyer B, Bootsma HJ, de Vries SP, Burghout P, Diavatopoulos DA, Hermans PW. 2012. Modified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media. mBio 3(4):e00079-00012. http://dx.doi.org/10.1128/mBio.00079-12.
16. Ho DK, Ram S, Nelson KL, Bonthuis PJ, Smith AL. 2007. lgtC expression modulates resistance to C4b deposition on an invasive nontypeable Haemophilus influenzae. J. Immunol. 178:1002-1012. http://dx.doi.org/10.4049/jimmunol.178.2.1002.
17. Clark SE, Snow J, Li J, Zola TA, Weiser JN. 2012. Phosphorylcholine allows for evasion ofbactericidal antibody by Haemophilus influenzae. PLoS Pathog. 8:e1002521. http://dx.doi.org/10.1371/journal.ppat.1002521.
18. Virji M, Weiser JN, Lindberg AA, Moxon ER. 1990. Antigenic similarities in lipopolysaccharides of Haemophilus and Neisseria and expression of a digalactoside structure also present on human cells. Microb. Pathog. 9:441-450. http://dx.doi.org/10.1016/0882-4010(90)90062-U.
19. Schweda EK, Twelkmeyer B, Li J. 2008. Profiling structural elements of short-chain lipopolysaccharide of non-typeable Haemophilus influenzae. Innate Immun. 14:199-211. http://dx.doi.org/10.1177/1753425908095958.
20. Holden HM, Rayment I, Thoden JB. 2003. Structure and function of enzymes of the Leloir pathway for galactose metabolism. J. Biol. Chem. 278:43885-43888. http://dx.doi.org/10.1074/jbc.R300025200.
21. Ehrenstein MR, Notley CA. 2010. The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 10:778-786. http://dx.doi.org/10.1038/nri2849.
22. Weiser JN, Pan N, McGowan KL, Musher D, Martin A, Richards J. 1998. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187: 631-640. http://dx.doi.org/10.1084/jem.187.4.631.
23. Engskog M. 2010. Structural and genetic characterization of lipopolysaccharides extracted from disease causing non-typeable Haemophilus influenzae strains. Doctoral thesis. Karolinska Institutet, Stockholm, Sweden. http://hdl.handle.net/10616/39835.
24. Weiser JN, Maskell DJ, Butler PD, Lindberg AA, Moxon ER. 1990. Characterization of repetitive sequences controlling phase variation of Haemophilus influenzae lipopolysaccharide. J. Bacteriol. 172:3304-3309.
25. Hood DW, Cox AD, Wakarchuk WW, Schur M, Schweda EK, Walsh SL, Deadman ME, Martin A, Moxon ER, Richards JC. 2001. Genetic basis for expression of the major globotetraose-containing lipopolysaccharide from H. influenzae strain Rd (RM118). Glycobiology 11:957-967. http://dx.doi.org/10.1093/glycob/11.11.957.
26. Deadman ME, Lundström SL, Schweda EK, Moxon ER, Hood DW. 2006. Specific amino acids of the glycosyltransferase LpsA direct the addition of glucose or galactose to the terminal inner core heptose of Haemophilus influenzae lipopolysaccharide via alternative linkages. J. Biol. Chem. 281:29455-29467. http://dx.doi.org/10.1074/jbc.M604908200.
27. De Chiara M, Hood D, Muzzi A, Pickard DJ, Perkins T, Pizza M, Dougan G, Rappuoli R, Moxon ER, Soriani M, Donati C. 2014. Genome sequencing of disease and carriage isolates of nontypeable Haemophilus influenzae identifies discrete population structure. Proc. Natl. Acad. Sci. U. S. A. 111:5439-5444. http://dx.doi.org/10.1073/pnas.1403353111.
28. Nichols WA, Gibson BW, Melaugh W, Lee NG, Sunshine M, Apicella MA. 1997. Identification of the ADP-L-glycero-D-manno-heptose-6-epimerase (rfaD) and heptosyltransferase II (rfaF) biosynthesis genes from nontypeable Haemophilus influenzae 2019. Infect. Immun. 65: 1377-1386.
29. Lee NG, Sunshine MG, Apicella MA. 1995. Molecular cloning and characterization of the nontypeable Haemophilus influenzae 2019 rfaE gene required for lipopolysaccharide biosynthesis. Infect. Immun. 63:818-824.
30. DeMaria TF, Apicella MA, Nichols WA, Leake ER. 1997. Evaluation of the virulence of nontypeable Haemophilus influenzae lipooligosaccharide htrB and rfaD mutants in the chinchilla model of otitis media. Infect. Immun. 65:4431-4435.
31. Erwin AL, Allen S, Ho DK, Bonthuis PJ, Jarisch J, Nelson KL, Tsao DL, Unrath WC, Watson ME, Jr, Gibson BW, Apicella MA, Smith AL. 2006. Role of lgtC in resistance of nontypeable Haemophilus influenzae strain R2866 to human serum. Infect. Immun. 74:6226-6235. http://dx.doi.org/10.1128/IAI.00722-06.
32. Nakamura S, Shchepetov M, Dalia AB, Clark SE, Murphy TF, Sethi S, Gilsdorf JR, Smith AL, Weiser JN. 2011. Molecular basis of increased serum resistance among pulmonary isolates of non-typeable Haemophilus influenzae. PLoS Pathog. 7:e1001247. http://dx.doi.org/10.1371/journal.ppat.1001247.
33. Micol R, Kayal S, Mahlaoui N, Beauté J, Brosselin P, Dudoit Y, Obenga G, Barlogis V, Aladjidi N, Kebaili K, Thomas C, Dulieu F, Monpoux F, Nové-Josserand R, Pellier I, Lambotte O, Salmon A, Masseau A, Galanaud P, Oksenhendler E, Tabone MD, Teira P, Coignard-Biehler H, Lanternier F, Join-Lambert O, Mouillot G, Theodorou I, Lecron JC, Alyanakian MA, Picard C, Blanche S, Hermine O, Suarez F, Debré M, Lecuit M, Lortholary O, Durandy A, Fischer A. 2012. Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia. J. Allergy Clin. Immunol. 129:770-777. http://dx.doi.org/10.1016/j.jaci.2011.09.047.
34. Poolman JT, Bakaletz L, Cripps A, Denoel PA, Forsgren A, Kyd J, Lobet Y. 2000. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine 19(Suppl 1):S108-S115. http://dx.doi.org/10.1016/S0264-410X(00)00288-7.
35. Hong W, Peng D, Rivera M, Gu XX. 2010. Protection against nontypeable Haemophilus influenzae challenges by mucosal vaccination with a detoxified lipooligosaccharide conjugate in two chinchilla models. Microbes Infect. 12:11-18. http://dx.doi.org/10.1016/j.micinf.2009.09.006.
36. Ueyama T, Gu XX, Tsai CM, Karpas AB, Lim DJ. 1999. Identification of common lipooligosaccharide types in isolates from patients with otitis media by monoclonal antibodies against nontypeable Haemophilus influenzae 9274. Clin. Diagn. Lab. Immunol. 6:96-100.
37. Gergova RT, Iankov ID, Haralambieva IH, Mitov IG. 2007. Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus spp. Curr. Microbiol. 54:85-90. http://dx.doi.org/10.1007/s00284-005-0463-6.
38. Poole J, Foster E, Chaloner K, Hunt J, Jennings MP, Bair T, Knudtson K, Christensen E, Munson RS, Jr, Winokur PL, Apicella MA. 2013. Analysis of nontypeable Haemophilus influenzae phase-variable genes during experimental human nasopharyngeal colonization. J. Infect. Dis. 208:720-727. http://dx.doi.org/10.1093/infdis/jit240.
39. Weiser JN, Love JM, Moxon ER. 1989. The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell 59:657-665. http://dx.doi.org/10.1016/0092-8674(89)90011-1.
40. Clark SE, Eichelberger KR, Weiser JN. 2013. Evasion of killing by human antibody and complement through multiple variations in the surface oligosaccharide of Haemophilus influenzae. Mol. Microbiol. 88:603-618. http://dx.doi.org/10.1111/mmi.12214.
41. Mukerji R, Mirza S, Roche AM, Widener RW, Croney CM, Rhee DK, Weiser JN, Szalai AJ, Briles DE. 2012. Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine. J. Immunol. 189:5327-5335. http://dx.doi.org/10.4049/jimmunol.1201967.
42. Klein U, Rajewsky K, Küppers R. 1998. Human immunoglobulin (Ig)M_IgD_peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188: 1679-1689. http://dx.doi.org/10.1084/jem.188.9.1679.
43. Klein U, Küppers R, Rajewsky K. 1997. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 89:1288-1298.
44. Tangye SG, Good KL. 2007. Human IgM_CD27_B cells: memory B cells or “memory” B cells? J. Immunol. 179:13-19. http://dx.doi.org/10.4049/jimmunol.179.1.13.
45. +B cells are crucial in secondary immune response by producing high affinity IgM. Clin. Immunol. 108:128-137. http://dx.doi.org/10.1016/S1521-6616(03)00092-5.
46. Carsetti R, Rosado MM, Donnanno S, Guazzi V, Soresina A, Meini A, Plebani A, Aiuti F, Quinti I. 2005. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J. Allergy Clin. Immunol. 115:412-417. http://dx.doi.org/10.1016/j.jaci.2004.10.048.
47. Kruetzmann S, Rosado MM, Weber H, Germing U, Tournilhac O, Peter HH, Berner R, Peters A, Boehm T, Plebani A, Quinti I, Carsetti R. 2003. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197:939-945. http://dx.doi.org/10.1084/jem.20022020.
48. Langereis JD, Franciosi L, Ulfman LH, Koenderman L. 2011. GM-CSF and TNF_modulate protein expression of human neutrophils visualized by fluorescence two-dimensional difference gel electrophoresis. Cytokine 56:422-429. http://dx.doi.org/10.1016/j.cyto.2011.06.025.
49. Gould JM, Weiser JN. 2001. Expression of C-reactive protein in the human respiratory tract. Infect. Immun. 69:1747-1754. http://dx.doi.org/10.1128/IAI.69.3.1747-1754.2001.
50. Langereis JD, Zomer A, Stunnenberg HG, Burghout P, Hermans PW. 2013. Nontypeable Haemophilus influenzae carbonic anhydrase is important for environmental and intracellular survival. J. Bacteriol. 195: 2737-2746. http://dx.doi.org/10.1128/JB.01870-12.
51. Herriott RM, Meyer EM, Vogt M. 1970. Defined nongrowth media for stage II development of competence in Haemophilus influenzae. J. Bacteriol. 101:517-524.
52. Jones PA, Samuels NM, Phillips NJ, Munson RS, Jr, Bozue JA, Arseneau JA, Nichols WA, Zaleski A, Gibson BW, Apicella MA. 2002. Haemophilus influenzae type b strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation. J. Biol. Chem. 277: 14598-14611. http://dx.doi.org/10.1074/jbc.M110986200.
53. Williams BJ, Morlin G, Valentine N, Smith AL. 2001. Serum resistance in an invasive, nontypeable Haemophilus influenzae strain. Infect. Immun. 69:695-705. http://dx.doi.org/10.1128/IAI.69.2.695-705.2001.
54. Hood DW, Deadman ME, Allen T, Masoud H, Martin A, Brisson JR, Fleischmann R, Venter JC, Richards J., Moxon ER. 1996. Use of the complete genome sequence information of Haemophilus influenzae strain Rd to investigate lipopolysaccharide biosynthesis. Mol. Microbiol. 22:951-965. http://dx.doi.org/10.1046/j.1365-2958.1996.01545.x.
55. Lysenko E, Richards J., Cox AD, Stewart A, Martin A, Kapoor M, Weiser JN. 2000. The position of phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae affects binding and sensitivity to C-reactive protein-mediated killing. Mol. Microbiol. 35:234-245. http://dx.doi.org/10.1046/j.1365-2958.2000.01707.x.
56. Puig C, Marti S, Hermans PW, de Jonge MI, Ardanuy C, Liñares J, Langereis JD. 2014. Incorporation of phosphorylcholine into the lipooligosaccharide of nontypeable Haemophilus influenzae does not correlate with the level of biofilm formation in vitro. Infect. Immun. 82:1591-1599. http://dx.doi.org/10.1128/IAI.01445-13.
57. de Vries SP, Burghout P, Langereis JD, Zomer A, Hermans PW, Bootsma HJ. 2013. Genetic requirements for Moraxella catarrhalis growth under iron-limiting conditions. Mol. Microbiol. 87:14-29. http://dx.doi.org/10.1111/mmi.12081.
58. Weiser JN, Pan N. 1998. Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide. Mol. Microbiol. 30:767-775. http://dx.doi.org/10.1046/j.1365-2958.1998.01108.x.